You are here: Industry Insights > Market News > China's Sinopharm COVID-19 vaccines arrive in Thailand

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

China's Sinopharm COVID-19 vaccines arrive in Thailand

firstwordpharmaJune 21, 2021

Tag: Sinopharm , COVID-19 , vaccines

Favorites

A batch of Sinopharm COVID-19 vaccines landed in Bangkok on Sunday, as reported China Daily.

China's Sinopharm COVID-19 vaccines arrive in Thailand

The Chulabhorn Royal Academy announced that 17,070 organisations and companies nationwide had registered to obtain the Sinopharm vaccine to inoculate their employees.

The country approved the vaccine for emergency use in May, following the approvals of AstraZeneca, Sinovac, Johnson & Johnson and Moderna vaccines.

Thailand aims to vaccinate about 70% of its nearly 70 million population by the end of the year.

Previous:Cuba encouraged by early trials of homegrown COVID-19 vaccine

Next:Urgently trying to work with AstraZeneca, SII, Indian govt to resume shipments of COVID-19 vaccines: WHO

New CRO Focused on Cannabis-based Drug Trials Launched

Biotech NewswireMay 23, 2024

Cannovation Clinical Research Partners takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development, commercialization, and launch phases.

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

PharmaSourcesMay 21, 2024

Selection of Commercial Models for Innovative Drugs

PharmaSourcesMay 21, 2024

China's Sinopharm COVID-19 vaccines arrive in Thailand | Pharmasources.com

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

China's Sinopharm COVID-19 vaccines arrive in Thailand

Related News

New CRO Focused on Cannabis-based Drug Trials Launched

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

Selection of Commercial Models for Innovative Drugs

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

You may like